Menu
Back to User profile » Prof. Dr. Raymond R Tjandrawinata
Papers published by Prof. Dr. Raymond R Tjandrawinata:
The Effect and Safety Assessment of Metformin and DLBS3233 (A Bioactive Fraction of Lagerstroemia speciosa and Cinnamomum burmannii) on Improving Metabolic Parameters in Women with Polycystic Ovary Syndrome
Hidayat ST, Mulyantoro I, Damas S, Tjandrawinata RR
International Journal of Women's Health 2023, 15:971-985
Published Date: 4 July 2023
Potential Antiaging Effects of DLBS1649, a Centella asiatica Bioactive Extract
Karsono AH, Tandrasasmita OM, Berlian G, Tjandrawinata RR
Journal of Experimental Pharmacology 2021, 13:781-795
Published Date: 11 August 2021
Antidiarrheal Effect of DLBS1Y62, a Bioactive Fraction of Uncaria gambir Roxb. Dried Sap Extract, in Wistar Rats
Wibowo DA, Nailufar F, Tjandrawinata RR
Journal of Experimental Pharmacology 2021, 13:669-675
Published Date: 15 July 2021
Gastroprotective Effect of DLBS2411 Bioactive Fraction from Cinnamomum burmannii Against Ethanol-Induced Gastric Damage in Rats
Tjandrawinata RR, Nailufar F
Journal of Experimental Pharmacology 2020, 12:87-95
Published Date: 20 March 2020
Bioactive fraction from Lagerstroemia speciosa leaves (DLBS3733) reduces fat droplet by inhibiting adipogenesis and lipogenesis
Karsono AH, Tandrasasmita OM, Tjandrawinata RR
Journal of Experimental Pharmacology 2019, 11:39-51
Published Date: 2 May 2019
Pharmacokinetic equivalence study of nonsteroidal anti-inflammatory drug etoricoxib
Tjandrawinata RR, Setiawati A, Nofiarny D, Susanto LW, Setiawati E
Clinical Pharmacology: Advances and Applications 2018, 10:43-51
Published Date: 6 April 2018
Dietary polyamines in Mediterranean diet and their health benefits
Tjandrawinata RR
Nutrition and Dietary Supplements 2016, 8:85-86
Published Date: 6 October 2016
Insulin sensitizer in prediabetes: a clinical study with DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa
Manaf A, Tjandrawinata RR, Malinda D
Drug Design, Development and Therapy 2016, 10:1279-1289
Published Date: 29 March 2016
Pharmacokinetic equivalence study of two formulations of the anticonvulsant pregabalin
Tjandrawinata RR, Setiawati E, Putri RSI, Gunawan VA, Ong F, Susanto LW, Nofiarny D
Clinical Pharmacology: Advances and Applications 2015, 7:69-75
Published Date: 20 April 2015
Anti-inflammatory, antiangiogenic, and apoptosis-inducing activity of DLBS1442, a bioactive fraction of Phaleria macrocarpa, in a RL95-2 cell line as a molecular model of endometriosis
Tandrasasmita OM, Sutanto AM, Arifin PF, Tjandrawinata RR
International Journal of Women's Health 2015, 7:161-169
Published Date: 3 February 2015
Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from Lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies
Tjandrawinata RR, Trisina J, Rahayu P, Prasetya LA, Hanafiah A, Rachmawati H
Drug Design, Development and Therapy 2014, 8:1585-1593
Published Date: 25 September 2014
Single dose pharmacokinetic equivalence study of two gabapentin preparations in healthy subjects
Tjandrawinata RR, Setiawati E, Putri RSI, Yunaidi DA, Amalia F, Susanto LW
Drug Design, Development and Therapy 2014, 8:1249-1255
Published Date: 4 September 2014
Molecular effects of bioactive fraction of Curcuma mangga (DLBS4847) as a downregulator of 5α-reductase activity pathways in prostatic epithelial cells
Karsono AH, Tandrasasmita OM, Tjandrawinata RR
Cancer Management and Research 2014, 6:267-278
Published Date: 6 June 2014
Hydrogen potassium adenosine triphosphatase activity inhibition and downregulation of its expression by bioactive fraction DLBS2411 from Cinnamomum burmannii in gastric parietal cells
Tjandrawinata RR, Nailufar F, Arifin PF
International Journal of General Medicine 2013, 6:807-815
Published Date: 23 September 2013
Bioequivalence study of two formulations of candesartan cilexetil tablet in healthy subjects under fasting conditions
Tjandrawinata RR, Setiawati E, Yunaidi DA, Simanjuntak R, Santoso ID, Susanto LW
Drug Design, Development and Therapy 2013, 7:841-847
Published Date: 20 August 2013
Bioequivalence study of two formulations of bisoprolol fumarate film-coated tablets in healthy subjects
Tjandrawinata RR, Setiawati E, Yunaidi DA, Santoso ID, Setiawati A, Susanto LW
Drug Design, Development and Therapy 2012, 6:311-316
Published Date: 30 October 2012
Glucose-lowering effect of DLBS3233 is mediated through phosphorylation of tyrosine and upregulation of PPARγ and GLUT4 expression
Tandrasasmita OM, Wulan DD, Nailufar F, Sinambela J, Tjandrawinata RR
International Journal of General Medicine 2011, 4:345-357
Published Date: 3 May 2011